annual shareholders equity:
$204.56M-$44.72M(-17.94%)Summary
- As of today (May 30, 2025), VRNA annual stockholders equity is $204.56 million, with the most recent change of -$44.72 million (-17.94%) on December 31, 2024.
- During the last 3 years, VRNA annual shareholders equity has risen by +$56.55 million (+38.21%).
- VRNA annual shareholders equity is now -17.94% below its all-time high of $249.28 million, reached on December 31, 2023.
Performance
VRNA Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$226.59M+$22.04M(+10.77%)Summary
- As of today (May 30, 2025), VRNA quarterly stockholders equity is $226.59 million, with the most recent change of +$22.04 million (+10.77%) on March 31, 2025.
- Over the past year, VRNA quarterly shareholders equity has increased by +$1.61 million (+0.71%).
- VRNA quarterly shareholders equity is now -18.12% below its all-time high of $276.75 million, reached on March 31, 2023.
Performance
VRNA quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VRNA Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.9% | +0.7% |
| 3 y3 years | +38.2% | +79.4% |
| 5 y5 years | +378.6% | +609.4% |
VRNA Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.9% | +38.2% | -18.1% | +104.4% |
| 5 y | 5-year | -17.9% | +378.6% | -18.1% | +859.1% |
| alltime | all time | -17.9% | >+9999.0% | -18.1% | >+9999.0% |
VRNA Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $226.59M(+10.8%) |
| Dec 2024 | $204.56M(-17.9%) | $204.56M(+56.8%) |
| Sep 2024 | - | $130.49M(-22.5%) |
| Jun 2024 | - | $168.27M(-25.2%) |
| Mar 2024 | - | $224.99M(-9.7%) |
| Dec 2023 | $249.28M(+8.2%) | $249.28M(-5.4%) |
| Sep 2023 | - | $263.53M(-3.5%) |
| Jun 2023 | - | $273.09M(-1.3%) |
| Mar 2023 | - | $276.75M(+20.1%) |
| Dec 2022 | $230.47M(+55.7%) | $230.47M(-3.0%) |
| Sep 2022 | - | $237.49M(+114.2%) |
| Jun 2022 | - | $110.88M(-12.2%) |
| Mar 2022 | - | $126.31M(-14.7%) |
| Dec 2021 | $148.00M(-19.9%) | $148.00M(-12.0%) |
| Sep 2021 | - | $168.20M(+8.9%) |
| Jun 2021 | - | $154.40M(-10.4%) |
| Mar 2021 | - | $172.41M(-6.7%) |
| Dec 2020 | $184.85M(+332.5%) | $184.85M(-6.5%) |
| Sep 2020 | - | $197.72M(+736.9%) |
| Jun 2020 | - | $23.62M(-26.0%) |
| Mar 2020 | - | $31.94M(-25.3%) |
| Dec 2019 | $42.74M(-46.9%) | $42.74M(-13.7%) |
| Sep 2019 | - | $49.52M(-21.6%) |
| Jun 2019 | - | $63.14M(-16.7%) |
| Mar 2019 | - | $75.80M(-5.8%) |
| Dec 2018 | $80.47M | $80.47M(-5.3%) |
| Sep 2018 | - | $84.95M(-2.7%) |
| Jun 2018 | - | $87.35M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $92.01M(-14.8%) |
| Dec 2017 | $107.95M(+153.8%) | $107.95M(-5.4%) |
| Sep 2017 | - | $114.17M(-5.8%) |
| Jun 2017 | - | $121.23M(+185.1%) |
| Dec 2016 | $42.53M(+428.3%) | $42.53M(+664.6%) |
| Jun 2016 | - | $5.56M(-30.9%) |
| Dec 2015 | $8.05M(-59.0%) | $8.05M(-44.2%) |
| Jun 2015 | - | $14.43M(-26.5%) |
| Dec 2014 | $19.62M(+475.3%) | $19.62M(-16.9%) |
| Jun 2014 | - | $23.60M(+592.2%) |
| Dec 2013 | $3.41M(-18.9%) | $3.41M(-14.6%) |
| Jun 2013 | - | $3.99M(-5.1%) |
| Dec 2012 | $4.21M(-33.1%) | $4.21M(-33.6%) |
| Jun 2012 | - | $6.34M(+0.7%) |
| Dec 2011 | $6.29M(+18.1%) | $6.29M(+48.3%) |
| Jun 2011 | - | $4.24M(-20.4%) |
| Dec 2010 | $5.33M(-26.5%) | $5.33M(-21.3%) |
| Jun 2010 | - | $6.76M(-6.7%) |
| Dec 2009 | $7.25M(+23.9%) | $7.25M(+36.2%) |
| Jun 2009 | - | $5.32M(-9.0%) |
| Dec 2008 | $5.85M(+2.1%) | $5.85M(-35.0%) |
| Jun 2008 | - | $9.00M(+57.1%) |
| Dec 2007 | $5.73M(-25.0%) | $5.73M(-17.1%) |
| Jun 2007 | - | $6.91M(-9.5%) |
| Dec 2006 | $7.64M(+353.3%) | $7.64M(+362.8%) |
| Jun 2006 | - | $1.65M(-2.0%) |
| Dec 2005 | $1.68M | $1.68M(-5.6%) |
| Jun 2005 | - | $1.78M |
FAQ
- What is Verona Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Verona Pharma?
- What is Verona Pharma annual shareholders equity year-on-year change?
- What is Verona Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Verona Pharma?
- What is Verona Pharma quarterly shareholders equity year-on-year change?
What is Verona Pharma annual stockholders equity?
The current annual shareholders equity of VRNA is $204.56M
What is the all time high annual shareholders equity for Verona Pharma?
Verona Pharma all-time high annual stockholders equity is $249.28M
What is Verona Pharma annual shareholders equity year-on-year change?
Over the past year, VRNA annual stockholders equity has changed by -$44.72M (-17.94%)
What is Verona Pharma quarterly stockholders equity?
The current quarterly shareholders equity of VRNA is $226.59M
What is the all time high quarterly shareholders equity for Verona Pharma?
Verona Pharma all-time high quarterly stockholders equity is $276.75M
What is Verona Pharma quarterly shareholders equity year-on-year change?
Over the past year, VRNA quarterly stockholders equity has changed by +$1.61M (+0.71%)